by PEPID Newsroom | Nov 2, 2018 | Alerts
Yesterday, November 1st, the federal Centers for Medicare & Medicaid Services (CMS) published their final rule for the Physician Fee Schedule for CY 2019, and Quality Payment Program (QPP)—regarding the Patients Over Paperwork Initiative, E&M requirements,...
by PEPID Newsroom | Nov 1, 2018 | Alerts
23andMe is the first direct-to-consumer (DTC) genetic test to be permitted by the FDA to market their pharmacogenomic reports providing information regarding genetic variants that may be associated with a patient’s ability to metabolize some medications to help inform...
by PEPID Newsroom | Oct 31, 2018 | Alerts
Yesterday the U.S. Food and Drug Administration approved Xofluza (balorxavir marhboxil), a new influenza treatment for acute uncomplicated influenza in people age 12 and older who have been symptomatic for no more than 2 days. This new drug, developed by Genentech,...
by PEPID Newsroom | Oct 22, 2018 | Alerts
The CDC is baffled by the cause of polio-like disease, Acute Flaccid Myelitis (AFM), affecting children in the United States. A reoccurring outbreak of AFM has been affecting Americans 21 and under since 2014. The CDC has recorded spikes in cases of Acute Flaccid...
by PEPID Newsroom | Oct 22, 2018 | Alerts
Toxic dinoflagellates algal blooms known as “red tides” are spreading across the Florida coastline, killing thousands of marine animals, and causing respiratory and gastrointestinal distress in residents. People in effected areas are warned not to swim in the water,...
